<DOC>
	<DOCNO>NCT02158910</DOCNO>
	<brief_summary>The purpose study investigation collection Aricept safety information dose increase Alzheimer 's disease patient .</brief_summary>
	<brief_title>A Plan Investigation Collection Aricept Safety Information With Dose Increase Alzheimer 's Disease Patients</brief_title>
	<detailed_description>This observational study systematically investigate domestic patient Alzheimer 's disease figure safety situation use Donepezil HCl 23mg . Additionally , dose Donepezil HCl increase , need examine safety Donepezil HCl 23mg depth patient Alzheimer 's disease comparing aspect occur adverse event type Donepezil HCl increase .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Inclusion Criteria 1 . Patients admit read use his/her biographical medical data word 2 . Patients maintain Aricept dosage least 3 month involve study Exclusion Criteria 1 . Hypersensitivity active substance excipients 2 . Breast feed 3 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Alzheimer 's disease</keyword>
</DOC>